Quarterly EPS earnings growth: Cortigent Medical (CRGT)

Corporate emblem and logo of Cortigent Inc (CRGT)

Cortigent, Inc. (CRGT) generates revenue through the implementation of brain-computer interfaces and stimulation systems for individuals with paralysis or blindness. The business leverages the humanitarian status of biomedicine, which minimizes external political threats. A fabless production model for implants via US contractors reduces operational risks. The quarterly EPS growth rate demonstrates capital dynamics, with the value maintained at .

Cortigent (CRGT) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 11/14/2026

Cortigent Inc - analytical breakdowns and key metrics (CRGT)

- share price and expert price forecast:
Stock Price Cortigent, Inc.|CRGT - Analyst Median Target
- company stock exchange capitalization indicators:
Market Capitalization Cortigent|CRGT - Full Takeover Company Value
- balance sheet net asset value indicators:
Book Value per Share Cortigent|CRGT - Total Stockholders' Equity|Market Value to Book Value Ratio cortigent.com|CRGT - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Cortigent, Inc.|CRGT - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio Cortigent Medical|CRGT - Aggregate Debt Obligations|Debts to Book Capitalization Cortigent Inc|CRGT - Long-Term Debt Volume|Company Short-Term Debt Cortigent|Quick Ratio cortigent.com
- earnings and valuation multiples indicators:
CRGT - Net Income|Future Profit Cortigent, Inc.|CRGT - Business Payback Period|Forward P/E Multiple Cortigent Medical|CRGT - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cortigent, Inc.|CRGT - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Cortigent|CRGT - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months cortigent.com|CRGT - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Cortigent, Inc.
- sales volume and revenue indicators:
CRGT - Company Sales Volume|Projected Sales Volume cortigent.com|CRGT - Price to Sales|Forward Price-to-Revenue Multiple CRGT
Summary company analytics:Cortigent - CRGT
Finished products of Cortigent

The specificity of Cortigent, Inc. (CRGT) lies in the development of proprietary neuroimplants, where financial success depends directly on clearing FDA regulatory hurdles and the outcomes of clinical trials. By analyzing the quarterly EPS growth rate, an investor can observe the rolling trend of net income per share over three months, which allows for the identification of the business's actual capitalization pace and prevents the purchase of an overvalued asset.

Competitors of Cortigent, Inc. (CRGT)

BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Bioscience Ltd) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Therapeutics, Inc. AXSM|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Year-over-year net earnings per share trend for the last twelve months|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Supernus Pharmaceuticals (SUPN)|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Therapeutics)|HRMY: Quarterly EPS earnings growth|BHVN (Biohaven Pharmaceutical) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx|Quarterly EPS earnings growth Trevi Corp|Quarterly EPS earnings growth PRAX|AVXL (anavex.com) - Year-over-year earnings per one share growth for the last 12 months|CeriBell Inc - Year-over-year net earnings per share growth for the last 12 months|PRTA (Prothena Corporation plc) - Year-over-year net earnings per share trend for the last twelve months|ALEC - Year-over-year earnings per share growth for the last twelve months|ANNX (Annexon Biosciences Inc.) - Year-over-year earnings per share growth for the last 12 months|OMER (omeros.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months NGNE|Year-over-year net earnings per share growth for the last 12 months ACIU|Quarterly EPS earnings growth Voyager Pharma|Year-over-year net earnings per share growth for the last 12 months NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth in annualized terms for the last twelve months|CGTX: Year-over-year net earnings per share growth for the last 12 months|Inhibikase Therapeutics, Inc. - Year-over-year earnings per share growth rate for the last twelve months|SAVA: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ASRT|COYA (coyatherapeutics.com) - Quarterly EPS earnings growth|Vistagen (VTGN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OVID (Ovid Rx)|Year-over-year net earnings per share change for the last twelve months Acumen Pharmaceuticals, Inc.|Quarterly EPS earnings growth CRVO (CervoMed Corporation)|Year-over-year earnings per share growth rate for the last twelve months ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year pepgen.com (PEPG)|JUNS: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RLMD|ANVS (Annovis Bio Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Grace Therapeutics, Inc. (GRCE)|Quarterly EPS earnings growth AIFF|Year-over-year earnings per share growth rate for the last twelve months KLTO|Year-over-year earnings per share growth for the last twelve months neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth in annualized terms for the last twelve months|MetaVia Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Year-over-year net earnings per share growth for the last 12 months|Passage Bio Inc. (PASG) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Neuphoria|Year-over-year net earnings per share growth for the last 12 months Minerva Neurosciences, Inc. (NERV)|Year-over-year earnings per share growth for the last twelve months Athira (ATHA)|Addex Therapeutics - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth in annualized terms for the last twelve months|PTIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Pasithea Therapeutics Corp KTTA|ATXI (Avenue Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months CARA|Earnings per share growth in annualized terms for the last twelve months chromocell.com CHRO|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals Inc)|Quarterly EPS earnings growth Marinus Pharma MRNS|nkgenbiotech.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)